This is the authors' abstract. We don't add key points for this paper.
A series of advanced renal cell carcinoma patients given clinical hormonal treatment is described. Eight cases (16.7%) showed objective signs of tumor regression with hormone therapy in our series of 43 consecutive cases of progressive metastatic renal cell carcinoma. Six out of 7 (objective) partial responses were from medroxyprogesterone acetate. The only case of complete regression of pulmonary metastases occurred in a female with testosterone therapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wagle et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: